1. "Predictors of Negative Symptom Domains in Outpatients with Schizophrenia: A Cross-Sectional Study"
    Octavia Căpățână et al, 2021, Journal of Evidence-Based Psychotherapies CrossRef
  2. Assessment and Treatment of Negative Symptoms in Schizophrenia—A Regional Perspective
    Istvan Bitter et al, 2022, Frontiers in Psychiatry CrossRef
  3. Comparative Effect of Escitalopram and Citalopram on Depressive Symptoms of Patients with Schizophrenia: A Double-Blind Randomized Controlled Trial
    Romina Hamzehpour et al, 2022, Global Journal of Medical, Pharmaceutical, and Biomedical Update CrossRef
  4. New Personality and Neurocommunication: Neurogenetics and Neural Networks, Psychoneuroimmunoendocrinology, 5P Medicine and 5G Technologies
    S. Bulgakova et al, 2021, Bulletin of Science and Practice CrossRef
  5. Role of Curcumin in the Management of Schizophrenia: A Narrative Review
    Damodharan Dinakaran et al, 2022, Indian Journal of Psychological Medicine CrossRef
  6. Healthcare Provider Engagement with a Novel Dashboard for Tracking Medication Ingestion: Impact on Treatment Decisions and Clinical Assessments for Adults with Schizophrenia
    Jeffrey M Cochran et al, 2022, Neuropsychiatric Disease and Treatment CrossRef
  7. Resting-State Brain Activity Dysfunctions in Schizophrenia and Their Associations with Negative Symptom Domains: An fMRI Study
    Giulia Maria Giordano et al, 2023, Brain Sciences CrossRef
  8. Neonatal phencyclidine as a model of sex-biased schizophrenia symptomatology in adolescent mice
    Ana Carolina Dutra-Tavares et al, 2023, Psychopharmacology CrossRef
  9. Management of cognitive and negative symptoms in schizophrenia
    Megan Maroney, 2022, Mental Health Clinician CrossRef
  10. Efficacy and safety of adjunctive therapy with fingolimod in patients with schizophrenia: A randomized, double-blind, placebo-controlled clinical trial
    Monire Karbalaee et al, 2023, Schizophrenia Research CrossRef
  11. The Many Faces of Negative Symptoms in Schizophrenia
    Mihaela Fadgyas Stanculete et al, 2022, Psychosis - Phenomenology, Psychopathology and Pathophysiology CrossRef
  12. Adjuvant palmitoylethanolamide therapy with risperidone improves negative symptoms in patients with schizophrenia: A randomized, double-blinded, placebo-controlled trial
    Anahita Salehi et al, 2022, Psychiatry Research CrossRef
  13. Low-Dose Ziprasidone in Combination with Sertraline for First-Episode Drug-Naïve Patients with Schizophrenia: a Randomized Controlled Trial
    Cheng Zhu et al, 2022, Neurotherapeutics CrossRef